RankingsPricing
  1. US-listed companies
  2. RESMED INC
  3. Financials
  4. EBITDA margin (%)

RESMED INCRMD

Market cap
$36.7B
P/E ratio
SummaryFinancials
Period EndEBITDA margin (%) YoY (%)
Jun 30, 202536.6+14.59%
Jun 30, 202431.9+4.01%
Jun 30, 202330.7-5.25%
Jun 30, 202232.4-2.28%
Jun 30, 202133.2+1.70%
Jun 30, 202032.6+16.46%
Jun 30, 201928-0.96%
Jun 30, 201828.3+8.64%
Jun 30, 201726-7.21%
Jun 30, 201628.1-2.35%
Jun 30, 201528.7-6.66%
Jun 30, 201430.8+7.61%
Jun 30, 201328.6+2.92%
Jun 30, 201227.8+2.34%
Jun 30, 201127.2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)